The S&P 500 and Nasdaq end at records.
IntelliPharmaceuticals has a bio-equivalent to OxyContin, but says it is harder to tamper with. The pharma company is hoping to gain a recommendation from an FDA committee on Wednesday.
Celgene had been accused of marketing off-label uses for two of its cancer treatments.
GSK is looking to expand its digital platforms.
NeuroDerm, Novavax and Nektar Therapeutics were among the biotech stock movers in premarket trading on July 24.
With Calyxt, perhaps you truly can have your cake and eat it too.
Amazon has been reinforcing its HIPAA-compliant offerings so that health-care providers and insurers can save and transfer customer data.
Credit Suisse lowered both its rating and price target on Pfizer's stock as expiring patents will weigh on earnings.